Tesla Stock (TSLA) Hits Record High Near $490 as Robotaxi Testing Accelerates — California Autopilot Deadline, Analyst Forecasts, and Key Risks in Focus

Tesla Stock (TSLA) Hits Record High Near $490 as Robotaxi Testing Accelerates — California Autopilot Deadline, Analyst Forecasts, and Key Risks in Focus

December 17, 2025 — Tesla, Inc. (NASDAQ: TSLA) is back at the center of the market’s imagination machine. Shares are trading around $489.88, after a record close near $490 that snapped a roughly one‑year “no new highs” streak and reignited the debate over what Tesla really is: car company, AI company, robotaxi platform, or all of the above. Investopedia The timing isn’t subtle. Over the last 48 hours, Tesla has stacked multiple headline catalysts: Elon Musk publicly pointing to driverless robotaxi testing, a fresh regulatory development in California that could have threatened sales but was temporarily put on hold, and
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands, Inc. (NASDAQ: TLRY) stock is back in the spotlight on December 17, 2025, as cannabis stocks react—again—to fast-moving headlines around potential U.S. federal marijuana rescheduling. In the latest session, TLRY traded around $13.94, up roughly 27% on the day, after swinging between about $10.32 and $14.54—a reminder that Tilray remains one of the market’s most headline-sensitive, momentum-driven names. So what changed this time? A cluster of reports and follow-on commentary about President Donald Trump and a possible executive order aimed at reclassifying marijuana—paired with the stock’s own structural catalysts (notably its recent 1-for-10 reverse split)—is amplifying both upside
UK Inflation Falls to 3.2% in November 2025, Fueling Bank of England Rate Cut Expectations

UK Inflation Falls to 3.2% in November 2025, Fueling Bank of England Rate Cut Expectations

UK inflation cooled more sharply than forecast in November, strengthening market expectations that the Bank of England (BoE) will cut interest rates at its December decision. Figures released by the Office for National Statistics (ONS) on Wednesday, 17 December 2025 show the Consumer Prices Index (CPI) inflation rate fell to 3.2% in the 12 months to November, down from 3.6% in October. On a month‑to‑month basis, CPI fell by 0.2%—a notable shift for a period that often includes pre‑Christmas price changes. Office for National Statistics The cooler‑than‑expected inflation report lands just one day before the BoE publishes its Monetary Policy
Gold Price Today in India (Dec 17, 2025): 24K, 22K, 18K Rates in Delhi, Mumbai, Chennai; MCX Near ₹1.35 Lakh as Silver Hits Record

Gold Price Today in India (Dec 17, 2025): 24K, 22K, 18K Rates in Delhi, Mumbai, Chennai; MCX Near ₹1.35 Lakh as Silver Hits Record

Gold prices in India steadied and edged higher on Wednesday, December 17, 2025, after a sharp round of profit-taking a day earlier snapped a record run. Retail rates across major cities moved up modestly, while MCX gold remained volatile near lifetime highs—and silver stole the spotlight, surging to fresh records above ₹2.05 lakh/kg in early trade. Reuters+3The Indian Express+3mint+3 The action is being driven by a familiar mix of factors: shifting expectations around US interest rates, a moving US dollar, and currency pressure at home—where a weaker rupee typically lifts the landed cost of imported bullion. Reuters+2Reuters+2 Gold rate today
17 December 2025
British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco p.l.c. (BAT) entered mid-December with its share price near multi-year highs, and the news flow on Wednesday, December 17, 2025 is very “capital allocation meets governance”: the company disclosed another daily share repurchase under its ongoing buyback programme and filed a director declaration under UK listing rules. Meanwhile, investors are still digesting BAT’s early-December FY2025 pre-close trading update, where management reaffirmed its medium-term growth algorithm but signaled that 2026 performance is likely to land at the lower end of its target range—largely because the U.S. vaping market remains distorted by illicit competition and uneven enforcement. Reuters+4Investing.com+4Moneyweb+4 Below
Diageo (DGE.L) Stock News Today: Guinness Maker Strikes $2.3bn Asahi Deal — What It Means for Diageo Shares on 17 December 2025

Diageo (DGE.L) Stock News Today: Guinness Maker Strikes $2.3bn Asahi Deal — What It Means for Diageo Shares on 17 December 2025

Diageo plc stock is firmly in the spotlight on 17 December 2025, after the Johnnie Walker and Guinness owner announced a major East Africa transaction that brings in fresh cash, reduces leverage, and reshapes how the group operates in the region. In a market that has been punishing global spirits makers for slowing demand (especially in the US and parts of Asia), Diageo’s decision to sell its controlling stake in East African Breweries (EABL) to Asahi is being read as more than a simple portfolio tweak. It’s a balance-sheet move, a “simplify the footprint” move, and—depending on your level of
17 December 2025
Unilever PLC Stock (UL/ULVR): Today’s News, Analyst Forecasts, and What the Magnum Spin-Off Changes for 2026

Unilever PLC Stock (UL/ULVR): Today’s News, Analyst Forecasts, and What the Magnum Spin-Off Changes for 2026

Unilever PLC stock is back in the spotlight on 17 December 2025 as investors digest a fast-moving mix of portfolio restructuring, governance drama tied to Ben & Jerry’s, and fresh analyst revisions that hint at a slightly slower growth runway after the group’s ice cream separation. In early trading, Unilever’s U.S.-listed ADR (NYSE: UL) traded around $64.33, after a prior close near $64.94. In London, Unilever shares fell 1.06% on Tuesday to £47.94, lagging the broader FTSE 100 in a risk-off session. MarketWatch That price action is the surface rippling above a deeper story: Unilever is trying to prove that
Lloyds Banking Group (LLOY) Share Price Today: Stock News, Analyst Forecasts and Key Risks as of 17 December 2025

Lloyds Banking Group (LLOY) Share Price Today: Stock News, Analyst Forecasts and Key Risks as of 17 December 2025

Lloyds Banking Group plc (LSE: LLOY) ended 17 December 2025 around the mid‑90p level, with Hargreaves Lansdown showing a closing snapshot of 95.72p (sell) / 95.80p (buy), up 0.74p (+0.78%) on the day. The same data set puts Lloyds’ market capitalisation at roughly £56.26bn, and shows the stock has gained about 71.6% over the past year, trading not far below a 52‑week high of 97.74p. Hargreaves Lansdown That’s the “where we are.” The more interesting question for investors (and for anyone watching UK bank stocks on Google News/Discover) is “what’s driving the debate now?” On 17 December, the answer is
17 December 2025
NatWest Group Plc Stock (NWG): Latest News, Forecasts and Analyst Views on 17 December 2025

NatWest Group Plc Stock (NWG): Latest News, Forecasts and Analyst Views on 17 December 2025

NatWest Group Plc shares are heading into the final stretch of 2025 with three storylines dominating investor attention: an accelerated push into “agentic AI” for retail customers, continued share buybacks that underline the bank’s capital-return strategy, and a tighter band of analyst price targets after a strong 2025 rally. Reuters+2TradingView+2 Below is a round-up of the most relevant, currently circulating news and analysis as of 17 December 2025, plus what the latest forecasts imply for NatWest’s stock into 2026. What’s driving NatWest shares today 1) NatWest joins UK “agentic AI” race — and regulators are watching closely Reuters reported today
17 December 2025
UK Stock Market Today (17 December 2025): FTSE 100 Set to Jump as UK Inflation Drops to 3.2% Ahead of Bank of England Rate Decision

UK Stock Market Today (17 December 2025): FTSE 100 Set to Jump as UK Inflation Drops to 3.2% Ahead of Bank of England Rate Decision

London shares are poised for a stronger start on Wednesday, 17 December 2025, after a sharper-than-expected drop in UK inflation reinforced expectations that the Bank of England will cut interest rates at its final policy meeting of the year on Thursday (18 December). Reuters+1 UK stock market snapshot: what traders are watching this morning Early indicators across UK markets point to a “rates relief” tone: This setup matters because the UK’s equity benchmarks are highly sensitive to shifts in rate expectations—especially through bank earnings assumptions, property and housebuilder sentiment, and the currency translation effect for globally exposed blue chips. The
Rolls-Royce (RR.L) Stock Update 17 December 2025: £200m Buyback, Defence Engine Tests, SMR Momentum and the Latest Analyst Forecasts

Rolls-Royce (RR.L) Stock Update 17 December 2025: £200m Buyback, Defence Engine Tests, SMR Momentum and the Latest Analyst Forecasts

LONDON — 17 December 2025 — Rolls-Royce Holdings plc stock (LSE: RR., often referenced as RR.L) is closing out 2025 with a familiar theme: cash generation plus operational execution, now reinforced by another shareholder-return move and a steady stream of programme milestones across civil aerospace, defence and power systems. As of the market close on 17 December 2025, Hargreaves Lansdown showed Rolls-Royce shares around 1,107p (sell) / 1,108.5p (buy), up 10p (+0.91%) on the day, with a 52-week high near 1,195p and a 52-week low near 557p. The same page indicated a market capitalisation of about £91.9bn. Hargreaves Lansdown Below
17 December 2025
GSK Stock News Today (Dec. 17, 2025): FDA Approves Twice‑Yearly Asthma Drug Exdensur as Analysts Reassess GSK plc’s 2026 Outlook

GSK Stock News Today (Dec. 17, 2025): FDA Approves Twice‑Yearly Asthma Drug Exdensur as Analysts Reassess GSK plc’s 2026 Outlook

Updated: 17 December 2025 GSK plc stock (LSE: GSK; NYSE: GSK) is in focus on Dec. 17 after a major U.S. regulatory win: the FDA approved Exdensur (depemokimab‑ulaa) for severe asthma—giving GSK a new, ultra‑long‑acting biologic that’s dosed just twice a year. The approval lands as the company approaches a leadership handover on Jan. 1, 2026, and as investors weigh whether GSK’s late‑2025 pipeline momentum can translate into durable earnings growth in 2026 and beyond. Reuters+2GSK+2 Below is a full, news-driven breakdown of what’s moving GSK stock today, the most important recent catalysts, and how current analyst forecasts and technical
17 December 2025

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop